Oncternal Therapeutics



Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer progression.

Richard Vincent
Rajesh Krishnan
Edwina S. Baskin-Bey
Acting Chief Medical Officer
Gunnar Kaufmann
Chief Scientific Officer
Chase Leavitt
General Counsel

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.